Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Thermally-Activated Delayed Fluorescence Nanoparticle Assemblies for Photodynamic Therapy

Projektbeschreibung

Krebsbehandlung mit Präzision

Die photodynamische Therapie (PDT) ist eine minimalinvasive Krebsbehandlung, bei der Laserlicht mit photosensibilisierenden Farbstoffen kombiniert wird, um Krebszellen abzutöten. Die photochemischen Reaktionen führen zur Bildung reaktiver Sauerstoffspezies, die den programmierten Zelltod bei Krebszellen auslösen. Ungeachtet ihrer vielversprechenden Möglichkeiten waren in der photodynamischen Therapie bisher nur begrenzte Fortschritte zu verzeichnen, da nur wenige Farbstoffe für den klinischen Einsatz zugelassen sind. Das Team des innerhalb der Marie-Skłodowska-Curie-Maßnahmen unterstützten Projekts TADF-PDT wird eine neue Klasse von Farbstoffen einführen, die auf thermisch aktivierter verzögerter Fluoreszenz (thermally-activated delayed fluorescence; TADF) beruhen. Diese effizienten TADF-Materialien werden mithilfe biokompatibler extrazellulärer Vesikel verabreicht, womit sie die Richtung zu einer Strategie der nächsten Generation für eine sicherere und gezieltere Krebsbehandlung weisen.

Ziel

Photodynamic Therapy (PDT) is a non-invasive cancer treatment that uses light-activated, photosensitising dyes to generate highly reactive oxygen species (ROS) within a localised biological environment, leading to the destruction of cancer cells, while sparing surrounding healthy tissue. The PDT process comprises two stages: administration of a dye, followed by irradiation with light. Since ROS is only generated at the light-activated sites, tissue destruction is highly localised and side effects are significantly reduced. The potential for PDT is clear. However, for all this potential, widespread adoption has stagnated: only three dyes have been approved for cancer treatment globally, while the dye most commonly studied in clinical trials - Photofrin - is a statistical mixture of oligomeric porphyrins. Dye design for many years has focussed on porphyrins derived from Photofrin, and more recently phosphorescent ruthenium(II) polypyridyl complexes. However, in this proposal, a new design strategy is proposed: thermally-activated delayed fluorescence (TADF) dyes are the targets of interest. These are all-organic compounds that have small singlet-triplet energy gaps, which causes them to undergo rapid intersystem crossing and reverse intersystem crossing between the singlet and triplet states. By accessing the triplet state, they can readily generate singlet oxygen, which is one form of ROS, marking their potential for PDT. These compounds have been widely used organic device applications, but their uses in biological applications such as imaging and particularly PDT are much less. This proposal addresses this gap, using novel, cationic, near-IR emitting, TADF dyes. Their delivery to cells will be achieved using biocompatible, Extracellular Vesicles (EVs), which have been shown to be improved PDT delivery agents over other methods.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-MSCA-2024-PF-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Netto-EU-Beitrag
€ 260 347,92
Adresse
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
Vereinigtes Königreich
Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten